Pablo
Pelegrin Vivancos
Catedraticos de Universidad
Hospital Vall d'Hebron
Barcelona, EspañaPublications in collaboration with researchers from Hospital Vall d'Hebron (5)
2024
-
Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production
Nature Communications, Vol. 15, Núm. 1
2023
-
The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis
eBioMedicine, Vol. 97
2022
-
First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism
Arthritis and Rheumatology, Vol. 74, Núm. 4, pp. 692-699
2020
-
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations
Journal of Clinical Immunology, Vol. 40, Núm. 7, pp. 987-1000
2014
-
The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response
Nature Immunology, Vol. 15, Núm. 8, pp. 738-748